10011 Results for "

Potent

" in MedChemExpress (MCE) Product Catalog:
Products (10011)

10011 Results for "Potent" in MCE Product Catalog:

486
486 Publications Verification
Art. -Nr.: HY-12815
CAS. Nr.: 210826-40-7
Reinheit:  99.62%
Synonyms: CP-456773; CRID3
Forschungsgebiete:  

Inflammation/Immunology

MCC950 (CP-456773; CRID3) is a potent and selective NLRP3 inhibitor with IC50s of 7.5 and 8.1 nM in BMDMs and HMDMs, respectively.
loading...
    loading...
486
486 Publications Verification
Art. -Nr.: HY-12815A
CAS. Nr.: 256373-96-3
Reinheit:  99.75%
Synonyms: CP-456773 sodium; CRID3 sodium salt
Forschungsgebiete:  

Inflammation/Immunology

MCC950 sodium (CP-456773 sodium; CRID3 sodium salt) is a potent, selective NLRP3 inhibitor with IC50s of 7.5 and 8.1 nM in BMDMs and HMDMs, respectively.
loading...
    loading...
485
485 Cited Publications
Art. -Nr.: HY-12031A
CAS. Nr.: 109511-58-2
Reinheit:  98.57%
Forschungsgebiete:  

Cancer

U0126 is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor .
loading...
    loading...
485
485 Cited Publications
Art. -Nr.: HY-12031
CAS. Nr.: 1173097-76-1
Reinheit:  98.92%
Forschungsgebiete:  

Cancer

U0126 (U0126-EtOH) is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor .
loading...
    loading...
315
315 Cited Publications
Art. -Nr.: HY-10182
CAS. Nr.: 252917-06-9
Reinheit:  99.43%
Synonyms: CHIR-99021; CT99021
Forschungsgebiete:  

Metabolic Disease Cancer

Laduviglusib (CHIR-99021) is a potent, selective and orally active GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal. Laduviglusib induces autophagy .
loading...
    loading...
315
315 Cited Publications
Art. -Nr.: HY-10182B
CAS. Nr.: 1782235-14-6
Reinheit:  99.07%
Synonyms: CHIR-99021 trihydrochloride; CT99021 trihydrochloride
Forschungsgebiete:  

Cancer

Laduviglusib (CHIR-99021) trihydrochloride is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib trihydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib trihydrochloride is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib trihydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib trihydrochloride induces autophagy .
loading...
    loading...
315
315 Cited Publications
Art. -Nr.: HY-10182A
CAS. Nr.: 1797989-42-4
Reinheit:  99.93%
Synonyms: CHIR-99021 monohydrochloride; CT99021 monohydrochloride
Forschungsgebiete:  

Cancer

Laduviglusib (CHIR-99021) monohydrochloride is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib monohydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib monohydrochloride is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib monohydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib monohydrochloride induces autophagy .
loading...
    loading...
314
314 Cited Publications
Art. -Nr.: HY-13818
CAS. Nr.: 19983-44-9
Reinheit:  99.58%
Target:  

STAT Apoptosis

Forschungsgebiete:  

Inflammation/Immunology Cancer

Stattic is a potent STAT3 inhibitor and inhibits STAT3 phosphorylation (at Y705 and S727) . Stattic inhibits the binding of a high affinity phosphopeptide for the SH2 domain of STAT3 . Stattic ameliorates the renal dysfunction in Alport syndrome (AS) mice .
loading...
    loading...
313
313 Cited Publications
Art. -Nr.: HY-15452
CAS. Nr.: 49843-98-3
Reinheit:  99.85%
Synonyms: EX-527
Target:  

Sirtuin

Forschungsgebiete:  

Inflammation/Immunology Cancer

Selisistat (EX-527) is a potent and selective SirT1 (Sir2 in Drosophila melanogaster) inhibitor with an IC50 of 123 nM for SirT1. Selisistat alleviates pathology in multiple animal and cell models of Huntington's disease .
loading...
    loading...
274
274 Cited Publications
Art. -Nr.: HY-50858
CAS. Nr.: 1092939-17-7
Synonyms: INCB018424 phosphate
Target:  

JAK Autophagy Mitophagy

Forschungsgebiete:  

Cancer

Ruxolitinib phosphate (INCB018424 phosphate) is a potent JAK1/2 inhibitor with IC50s of 3.3 nM/2.8 nM, respectively, showing more than 130-fold selectivity over JAK3.
loading...
    loading...
259
259 Cited Publications
Art. -Nr.: HY-13757
CAS. Nr.: 54965-24-1
Reinheit:  99.93%
Synonyms: ICI 46474; (Z)-Tamoxifen Citrate; trans-Tamoxifen Citrate
Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells.Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively. Tamoxifen Citrate activates autophagy and induces apoptosis. Tamoxifen Citrate can also be used to induce gene knockout in CreER transgenic mice .
loading...
    loading...
254
254 Cited Publications
Art. -Nr.: HY-12726
CAS. Nr.: 950455-15-9
Reinheit:  99.70%
Target:  

Ferroptosis

Forschungsgebiete:  

Cancer

Liproxstatin-1 is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM) .
loading...
    loading...
254
254 Cited Publications
Art. -Nr.: HY-12726A
CAS. Nr.: 2250025-95-5
Reinheit:  99.31%
Target:  

Ferroptosis

Forschungsgebiete:  

Cancer

Liproxstatin-1 hydrochloride is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM) .
loading...
    loading...
251
251 Cited Publications
Art. -Nr.: HY-15531
CAS. Nr.: 1257044-40-8
Reinheit:  99.95%
Synonyms: ABT-199; GDC-0199; RG7601
Target:  

Bcl-2 Family Autophagy

Forschungsgebiete:  

Cancer

Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM. Venetoclax induces autophagy .
loading...
    loading...
223
223 Cited Publications
Art. -Nr.: HY-16578
CAS. Nr.: 22978-25-2
Target:  

PPAR

Forschungsgebiete:  

Cancer

GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively.
loading...
    loading...
219
219 Cited Publications
Art. -Nr.: HY-B0795
CAS. Nr.: 326914-06-1
Target:  

mTOR Autophagy

Forschungsgebiete:  

Cancer

MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes .
loading...
    loading...
195
195 Cited Publications
Art. -Nr.: HY-15144
CAS. Nr.: 58880-19-6
Reinheit:  99.53%
Synonyms: TSA
Trichostatin A (TSA) is a potent and specific inhibitor of HDAC class I/II, with an IC50 value of 1.8 nM for HDAC .
loading...
    loading...
192
192 Cited Publications
Art. -Nr.: HY-15979A
CAS. Nr.: 130964-39-5
Target:  

PKA Autophagy

Forschungsgebiete:  

Others

H-89 dihydrochloride is a potent and selective inhibitor of protein kinase A (PKA) with an IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase.
loading...
    loading...
192
192 Cited Publications
Art. -Nr.: HY-15979
CAS. Nr.: 127243-85-0
Target:  

PKA Autophagy

Forschungsgebiete:  

Neurological Disease

H-89 is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase, and others kinases.
loading...
    loading...
186
186 Cited Publications
Art. -Nr.: HY-13630
CAS. Nr.: 117091-64-2
Reinheit:  99.28%
Synonyms: BMY-40481
Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor to prevent re-ligation of DNA strands. Etoposide phosphate is the phosphate ester proagent of etoposide and is considered as active equivalent to Etoposide. Etoposide phosphate induces cell cycle arrest, apoptosis, and autophagy.
loading...
    loading...